IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 116 filers reported holding IVERIC BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,609,120 | -45.7% | 168,000 | -66.4% | 0.19% | -46.8% |
Q1 2023 | $12,165,000 | -3.3% | 500,000 | -14.9% | 0.36% | +1.7% |
Q4 2022 | $12,576,234 | -32.2% | 587,400 | -43.2% | 0.35% | -34.4% |
Q3 2022 | $18,553,000 | -7.6% | 1,034,169 | -50.5% | 0.54% | -14.5% |
Q2 2022 | $20,086,000 | -77.2% | 2,087,956 | -60.0% | 0.63% | -64.3% |
Q1 2022 | $87,944,000 | -59.4% | 5,225,415 | -59.7% | 1.76% | +5.4% |
Q4 2021 | $216,692,000 | +78.6% | 12,960,000 | +73.5% | 1.67% | -5.2% |
Q3 2021 | $121,342,000 | +109.7% | 7,471,798 | -18.5% | 1.76% | +368.9% |
Q2 2021 | $57,870,000 | +104.2% | 9,171,024 | +100.0% | 0.38% | +5.0% |
Q1 2021 | $28,338,000 | -8.5% | 4,585,512 | +2.3% | 0.36% | +7.8% |
Q4 2020 | $30,976,000 | +57.8% | 4,482,713 | +28.8% | 0.33% | +15.7% |
Q3 2020 | $19,635,000 | +10.6% | 3,481,431 | 0.0% | 0.29% | -0.3% |
Q2 2020 | $17,755,000 | +274.7% | 3,481,431 | +152.8% | 0.29% | +134.1% |
Q1 2020 | $4,738,000 | -44.2% | 1,377,289 | +39.1% | 0.12% | -27.2% |
Q4 2019 | $8,497,000 | – | 990,289 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,914,250 | $28,035,000 | 11.91% |
Ally Bridge Group (NY) LLC | 650,000 | $6,253,000 | 5.70% |
Vivo Capital, LLC | 5,238,634 | $50,396,000 | 5.06% |
COMMODORE CAPITAL LP | 2,409,961 | $23,184,000 | 4.90% |
Finepoint Capital LP | 987,600 | $9,501,000 | 3.28% |
ACUTA CAPITAL PARTNERS, LLC | 563,607 | $5,422,000 | 3.02% |
Deep Track Capital, LP | 4,500,000 | $43,290,000 | 2.85% |
Yiheng Capital Management, L.P. | 5,058,585 | $48,664,000 | 2.78% |
Samsara BioCapital, LLC | 1,010,051 | $9,717,000 | 2.59% |
Ghost Tree Capital, LLC | 500,000 | $4,810,000 | 2.50% |